D-Serine for slowing Parkinson's disease progression
Part of Brain & nervous system clinical trials.
This study tests whether a supplement called D-serine can slow the progression of Parkinson's disease. It is for people diagnosed within the last 5 years who have mild to moderate symptoms and are not yet dependent on a wheelchair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease within the last 5 years.
- You have had a DaTscan brain scan that confirmed your Parkinson's diagnosis.
- You can walk without help or with only minor balance issues (Hoehn and Yahr stage less than 3).
- You are between 40 and 80 years old.
- You do not have dementia, other brain disorders, or severe kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
This trial tests if taking daily amino acid supplements helps people with Parkinson's disease. You need to be on stable Parkinson's medication for at least 3 months.
This trial tests whether a supplement called L-theanine and a Mediterranean diet can improve sleep, digestion, and inflammation in early-stage Parkinson's disease. It may help if you are in stage 1 and live with a healthy partner.
This trial tests whether a supplement called nicotinamide riboside (NR) can help people with rare forms of parkinsonism (PSP, MSA, or CBS). It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real supplement or a placebo.
This study tests whether a supplement called resveratrol (found naturally in grapes and berries) can help slow or improve Parkinson's disease symptoms. You'll take resveratrol pills or a placebo while researchers monitor your memory, movement, and overall health.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
Hear when a new Parkinson s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.